Finally, it sends signals to your brain that reduce your appetite and food cravings
[8] [9] Understanding these broad systemic effects is essential when considering potential cardiovascular changes, including alterations in heart rate, that some patients may experience during semaglutide therapy
That flexibility may improve convenience and long-term adherence for some patients
After previously announcing a rebrand and reformulation to Rybelsus in February 2026 to make the treatment more easily recognizable and bioavailable, Novo Nordisk announced that the Ozempic pill will be available for adults with type 2 diabetes in the United States starting Monday, May 4, 2026
In practice, some prescribers may use semaglutide off-label in selected patients who have insulin resistance, excess weight, or features of metabolic syndrome, but this should only happen under medical supervision
Prospective randomized controlled trials are needed to evaluate larger cohorts of patients to determine if semaglutide once-weekly may close the gap between lifestyle intervention and revision surgery to treat weight recidivism or insufficient weight loss after BS
